Personal information

Activities

Collapse all

Works (5)

Design and sample size determination for multiple‐dose randomized phase II trials for dose optimization

Statistics in Medicine
2024-07-10 | Journal article
DOI: 10.1002/sim.10093
Contributors: Peng Yang; Daniel Li; Ruitao Lin; Bo Huang; Ying Yuan
Source: check_circle
Crossref

SAM: Self-Adapting Mixture Prior to Dynamically Borrow Information from Historical Data in Clinical Trials

Biometrics
2023-12-01 | Journal article
DOI: 10.1111/biom.13927
Contributors: Peng Yang; Yuansong Zhao; Lei Nie; Jonathon Vallejo; Ying Yuan
Source: check_circle
Crossref

A novel Bayesian model for assessing intratumor heterogeneity of tumor infiltrating leukocytes with multi-region gene expression sequencing

2023-10-29 | Preprint
DOI: 10.1101/2023.10.24.563820
Contributors: Peng Yang; Shawna M. Hubert; P. Andrew Futreal; Xingzhi Song; Jianhua Zhang; J. Jack Lee; Ignacio Wistuba; Ying Yuan; Jianjun Zhang; Ziyi Li
Source: check_circle
Crossref

Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression

Nature Biotechnology
2022-11 | Journal article
DOI: 10.1038/s41587-022-01342-x
Contributors: Shaolong Cao; Jennifer R. Wang; Shuangxi Ji; Peng Yang; Yaoyi Dai; Shuai Guo; Matthew D. Montierth; John Paul Shen; Xiao Zhao; Jingxiao Chen et al.
Source: check_circle
Crossref

Tumor cell total mRNA expression shapes the molecular and clinical phenotype of cancer

2020-10-02 | Other
DOI: 10.1101/2020.09.30.306795
Contributors: Shaolong Cao; Jennifer R. Wang; Shuangxi Ji; Peng Yang; Matthew D. Montierth; Shuai Guo; John Paul Shen; Xiao Zhao; Jingxiao Chen; Jaewon James Lee et al.
Source: check_circle
Crossref
How many people are using ORCID?